ESOMEPRAZOLE 40mg. IP + LEVOSULPIRIDE 75mg. IP

Belongs to the therapeutic class of antacid and anti-reflux that helps in the relief of acid-related indigestion, and heartburn. Inhibits gastric acid secretion and acid-related indigestion and ulcers. Stimulates gastrointestinal motility and prevents reflux. Yields a significant improvement in clinical signs and symptoms of gastroesophageal reflux disease. Provides greater acid control than lansoprazole, omeprazole, pantoprazole, and rabeprazole in patients with symptoms of gastroesophageal reflux disease. (Kerstin Röhss, 2004) Maintains intragastric pH greater than 4 for a longer period than omeprazole 40mg. (R. Jones T. P., 2008) An effective and safe drug in the treatment of dysmotility-like functional dyspepsia and non-erosive reflux disease. (R Lozano, 2007)